Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report)’s share price hit a new 52-week low on Tuesday . The company traded as low as GBX 2.21 ($0.03) and last traded at GBX 3 ($0.04), with a volume of 579069 shares trading hands. The stock had previously closed at GBX 6.12 ($0.08).
Celadon Pharmaceuticals Price Performance
The stock’s 50 day moving average is GBX 16.90 and its two-hundred day moving average is GBX 21.21. The company has a debt-to-equity ratio of 196.67, a quick ratio of 6.97 and a current ratio of 1.92. The stock has a market capitalization of £1.84 million, a PE ratio of -0.38 and a beta of -0.26.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Top Stocks Investing in 5G Technology
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Buy P&G Now, Before It Sets A New All-Time High
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png?v=20221109120024&h=45&w=95&zc=2){kind=logo}